Patent application number | Description | Published |
20100062413 | METHOD OF EVALUATING IBD, AMINO ACID DATA PROCESSOR, AMINO ACID DATA-PROCESSING METHOD, AMINO ACID DATA-PROCESSING SYSTEM, AMINO-ACID DATA-PROCESSING PROGRAM AND RECORDING MEDIUM - According to the method of evaluating IBD of the present invention, amino acid concentration data on the concentration value of amino acid in blood collected from a subject to be evaluated is measured, and an inflammatory bowel disease state in the subject is evaluated based on the measured amino acid concentration data of the subject. | 03-11-2010 |
20110003975 | METHOD OF DENATURING WHEY PROTEIN - Provided is a method of producing a denatured whey protein which has an improved heat stability without using an additive such as an organic solvent. Also provided is a denatured whey protein produced by this method. A method of producing a denatured whey protein which comprises contacting and mixing a whey protein solution with a whey protein solution that is flowing as a thin film in the form of a rotating cylinder, and thus shearing the same at a temperature ranging form 76 to 120° C. at a shear speed of 5,000 s | 01-06-2011 |
20110060046 | AGENT AND FOOD FOR PREVENTING/IMPROVING FUNCTIONAL DIGESTIVE DISORDER - Provided is an agent for the prophylaxis or improvement of functional gastrointestinal disorders, which contains glutamic acid or a salt thereof other than arginine glutamate, and arginine or a salt thereof other than arginine glutamate, as active ingredients. The prophylactic or improvement agent can be produced conveniently and at low cost and is high safe and particularly effective for functional dyspepsia (FD) such as abdominal pain, heavy stomach, heartburn and the like, and upper gastrointestinal dysfunction such as esophageal reflux (GERD) and the like. | 03-10-2011 |
Patent application number | Description | Published |
20090277786 | PLATING PROCESSING LINE - A plating processing line or system includes a plurality of surface processing apparatus including a surface processing apparatus for processing a surface of an object to be treated by introducing a treatment liquid to the surface, and a conveyer unit for conveying the object to be treated, which is disposed between the respective surface processing apparatus linearly or in a curved manner. Each of the surface processing apparatus includes a positioning unit for positioning the object to be treated, which has been conveyed by the conveyer unit to a predetermined position, at which the object is subjected to a pre-plating process or a plating process as a surface processing. | 11-12-2009 |
20100078326 | PLATING PRETREATMENT APPARATUS AND METHOD FOR CYLINDER BLOCK - The present invention provides an apparatus for plating pretreatment of a cylinder block that includes an electrode performing a plating pretreatment of the cylinder inner wall surface. A gap flow channel communicates with an in-electrode flow channel at a position closest to a seal jig, the gap flow channel being adapted to introduce a treatment liquid to the cylinder inner wall surface, the in-electrode flow channel being adapted to receive the treatment liquid having passed through a communicating hole. The present invention is provided a method for pretreating before plating a cylinder block including disposing an electrode to face the cylinder inner wall surface so as to form a gap flow channel, and introducing a treatment liquid to the gap flow channel thereby flowing through the treatment liquid toward a seal jig and then into an in-electrode flow channel through a communicating hole. | 04-01-2010 |
20100104738 | PLATING PRETREATMENT APPARATUS AND METHOD FOR MULTI-CYLINDER BLOCK - A plating pretreatment apparatus for a multi-cylinder block includes a plurality of cylinders that performs a plating pretreatment of a cylinder inner wall surface of each of the cylinders using an electrode disposed so as to oppose to the cylinder inner wall surface by sealing one end of the cylinder inner wall surface and introducing a treatment liquid to the cylinder inner wall surface. In such plating pretreatment apparatus, at least one of a power supply device that supplies electricity to the cylinder block and the electrode and a liquid feed pump that feeds the treatment liquid into a gap between the cylinder inner wall surface and the electrode is provided for each of the cylinders. | 04-29-2010 |
20100314836 | SEALING JIG AND SEALING METHOD FOR CYLINDER BLOCK PLATING APPARATUS - A cylinder block plating apparatus preplates or plates a cylinder bore of each cylinder in a cylinder block of a multi-cylinder engine using a process liquid introduced into the cylinder bore in a condition of sealing an end of the cylinder bore when a communication hole is formed at the end of the cylinder bore, the cylinder block plating apparatus includes a sealing jig including a sealing unit including a cylinder bore seal for sealing the end of an inner peripheral surface of the cylinder bore and a communication hole seal for sealing a portion, near a communication hole, opposite to the cylinder inner peripheral surface, and a clamping unit disposed in the sealing unit to be pushed open and adapted to cause the communication hole seal to seal the portion located on the opposite side of the cylinder bore near the communication hole. The sealing is performed by sealing the end of an inner peripheral surface of the cylinder bore, and sealing a portion located on an opposite side of the cylinder bore in a periphery of the communication hole. | 12-16-2010 |
Patent application number | Description | Published |
20090018161 | METHOD FOR PROMOTING GASTROINTESTINAL FUNCTION AND METHOD FOR SCREENING FOR PROMOTER OF GASTROINTESTINAL FUNCTION - The present invention provides a more effective gastrointestinal function promoter. The present invention also provides a method for the prophylaxis or improvement of functional gastrointestinal disorders, a method for appetite regulation and the like. The present invention also provides a method for screening for a substance capable of promoting a gastrointestinal function. The present invention provides a gastrointestinal function promoter containing a T1R agonist as an active ingredient and a method for the prophylaxis or improvement of functional gastrointestinal disorders, a method for appetite regulation and the like by administering a T1R agonist. The present invention also provides a method of screening for a substance capable of promoting a gastrointestinal function which method uses a cell expressing T1R receptor. | 01-15-2009 |
20090093540 | ANTI-TUMOR COMPOSITION - The present invention provides compositions having, as active ingredients, a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided. | 04-09-2009 |
20100069486 | ANTI-TUMOR COMPOSITION - The present invention provides composition having as active ingredients a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided. | 03-18-2010 |
20100216755 | ANTI-TUMOR AGENT - The present application provides a method for the treatment of tumors where the lethal dose of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is increased to twice or more, the toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, gastrointestinal toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, hepatic toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, and/or cardiovascular toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, by administering to a subject in need thereof a composition containing:
| 08-26-2010 |
20120058497 | DIAGNOSTIC REAGENT FOR CROHN'S DISEASE - The present invention provides a reagent and a method of safely, conveniently, and specifically diagnosing Crohn's disease. Provided are a diagnostic method for Crohn's disease in a subject, including measuring antibodies against one kind or more of dietary components selected from the group consisting of grapefruit, alfalfa, avocado, cabbage, green pepper, lettuce, onion, potato (white), spinach, tomato, oat, pecan, yeast, cane sugar, celery, buckwheat, corn, rice and soy, and a diagnostic reagent or kit for Crohn's disease, containing the above-mentioned preparation of a dietary component. | 03-08-2012 |
Patent application number | Description | Published |
20080233508 | PROCESS FOR PRODUCING TONER FOR ELECTROPHOTOGRAPHY - The present invention relates to a process for producing a toner for electrophotography, including:
| 09-25-2008 |
20100183969 | CROSSLINKED RESIN PARTICLE DISPERSION LIQUID - The present invention relates to a toner for electrophotography which has a small particle size and is excellent in all of low-temperature fusing ability, anti-hot offset property and image characteristics and a process for producing the toner, as well as to a dispersion of crosslinked resin particles which is used for production of the toner for electrophotography and a process for producing the dispersion of crosslinked resin particles. The dispersion of crosslinked resin particles having a volume median particle size (D | 07-22-2010 |
20110223531 | PROCESS FOR PRODUCING TONER FOR ELECTROPHOTOGRAPHY - The present invention relates to a toner for electrophotography which exhibits an excellent heat-resistant storage property and a wide fusing temperature range, and a process for producing the toner for electrophotography. There are provided a process for producing a toner for electrophotography which includes (A) a step of emulsifying a resin binder containing a polyester having a constitutional unit derived from a trivalent or higher-valent carboxylic acid in an aqueous medium; (B) a step of aggregating emulsified particles contained in an emulsion obtained in the step (A); and (C) a step of coalescing aggregated particles obtained in the step (B), said process further including the following steps which are to be conducted after the step (A): (a) a step of adding a compound having at least one functional group selected from the group consisting of an oxazoline group and a glycidyl group; and (b) a step of forming a chemical bond between the compound having the at least one functional group and the resin binder containing the polyester, as well as a toner for electrophotography obtained by the process. | 09-15-2011 |
20120251940 | PROCESS FOR PRODUCING A TONER FOR ELECTROPHOTOGRAPHY - The invention provides a process for producing a toner for electrophotography including the following (1) to (4): (1): adding an aggregating agent to a resin particle dispersion (a) so as to attain an aggregating agent concentration Ea (wt %), to thereby produce an aggregated particle dispersion (A); (2): adding a resin microparticle dispersion (b) to the dispersion (A), to thereby produce a dispersion (B) having an aggregating agent concentration Eb (wt %) satisfying 0.60≦Eb/Ea<1; (3): modifying the aggregating agent concentration of the dispersion (B), to thereby produce a dispersion (C) of resin microparticle-deposited aggregated particles, having an aggregating agent concentration Ec (wt %) satisfying 010-04-2012 | |
Patent application number | Description | Published |
20100076044 | THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALPHA PRODUCTION INHIBITOR - Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent for inflammatory bowel disease comprising at least one amino acid selected from the group consisting of lysine, histidine, phenylalanine, methionine, tryptophan, glutamine, glycine, cysteine, cystine and threonine, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day; and a TNF-α production inhibitor comprising an amino acid selected from the group consisting of histidine, phenylalanine and tryptophan, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day. | 03-25-2010 |
20120329846 | THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALPHA PRODUCTION INHIBITOR - Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent for inflammatory bowel disease comprising at least one amino acid selected from the group consisting of lysine, histidine, phenylalanine, methionine, tryptophan, glutamine, glycine, cysteine, cystine and threonine, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day; and a TNF-α production inhibitor comprising an amino acid selected from the group consisting of histidine, phenylalanine and tryptophan, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day. | 12-27-2012 |